Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00195585 | Study Evaluating Isovorin in Colon Cancer | PHASE3 | COMPLETED | 650 | — | — | Oct 1, 2002 | Feb 1, 2006 | Aug 13, 2009 | 1 | Japan |
| Name | Type | Description |
|---|---|---|
| Isovorin | DRUG | - |
| UFT | DRUG | - |
Inclusion Criteria: * Dukes C, Cure A colon cancer diagnosed histologically or cytologically * Normal organ function of bone marrow, heart, liver and kidney * Age 20-75 Other inclusion applies Exclusion Criteria: * Serious bone marrow suppression, infection, heart disease or complication * Famil...